MedTrace Logo

Comparing the Effects of Front-of-Package Labeling Schemes in Indonesia

NCT07526584 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2026-04-13

No results posted yet for this study

Summary

The goal of this study is to examine what type of front-of-package label (FOPL) would be most effective at discouraging consumption of products high in nutrients of concern in Indonesia. The main questions this experiment aims to answer are:

1. Would nutrient warning labels be more effective at discouraging consumption of products high in nutrients of concern compared to the Nutri-Level label?
2. Would nutrient warning labels improve consumers' ability to identify unhealthy products compared to the Nutri-Level label?

Additionally, this experiment also aims to determine how should nutrient warning labels be designed to most effectively discourage consumption of products high in nutrients of concern among Indonesian consumers.

Conditions

  • Nutrition
  • Obesity & Overweight

Interventions

BEHAVIORAL

Nutrient Warning Label

Presentation of food products with one or more nutrient warning labels (black octagons) indicating that the product is high in sugar, salt, and/or fat.

BEHAVIORAL

Nutri-Level

Presentation of food products with a Nutri-Level summary nutrition label assigning a letter grade (A-D) based on sugar, salt, and/or fat content.

Sponsors & Collaborators

  • Bloomberg Philanthropies

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Lindsey S Taillie, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07526584 on ClinicalTrials.gov